EU Vaccines Strategy

GPTKB entity

Statements (37)
Predicate Object
gptkbp:instanceOf gptkb:public_policy
gptkbp:announced 17 June 2020
European Commission President Ursula von der Leyen
gptkbp:appliesTo European Union member states
gptkbp:coordinates European Commission Directorate-General for Health and Food Safety
gptkbp:focus vaccine distribution
vaccine safety
vaccine manufacturing
vaccine efficacy
vaccine accessibility
vaccine research and development
gptkbp:fundedBy gptkb:EU_budget
Emergency Support Instrument
gptkbp:goal coordinate vaccination efforts across the EU
secure sufficient supplies of vaccines
support development and manufacturing of vaccines
ensure timely access to COVID-19 vaccines for all EU member states
https://www.w3.org/2000/01/rdf-schema#label EU Vaccines Strategy
gptkbp:implementedIn gptkb:European_Parliament
gptkbp:negotiatedBy gptkb:Moderna
gptkb:AstraZeneca
gptkb:Johnson_&_Johnson
gptkb:Novavax
gptkb:CureVac
gptkb:Valneva
gptkb:Pfizer-BioNTech
Sanofi-GSK
gptkbp:relatedTo gptkb:COVAX
gptkb:EU_Digital_COVID_Certificate
HERA (Health Emergency Preparedness and Response Authority)
European Health Union
gptkbp:startDate 2020
gptkbp:target gptkb:COVID-19
gptkbp:type Advance Purchase Agreements
gptkbp:website https://ec.europa.eu/info/live-work-travel-eu/coronavirus-response/public-health/eu-vaccines-strategy_en
gptkbp:bfsParent gptkb:COVID-19_vaccination_campaign
gptkbp:bfsLayer 6